CN113817792A - Application of marine biological polypeptide in preparation of medicine for treating osteoporosis - Google Patents
Application of marine biological polypeptide in preparation of medicine for treating osteoporosis Download PDFInfo
- Publication number
- CN113817792A CN113817792A CN202111408458.7A CN202111408458A CN113817792A CN 113817792 A CN113817792 A CN 113817792A CN 202111408458 A CN202111408458 A CN 202111408458A CN 113817792 A CN113817792 A CN 113817792A
- Authority
- CN
- China
- Prior art keywords
- clam
- polypeptide
- powder
- wrinkle
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Water Supply & Treatment (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention provides application of marine biological polypeptide in preparing a medicine for treating osteoporosis, and belongs to the technical field of marine biology. The invention aims to solve the technical problem of providing a new medicament for treating osteoporosis. In order to solve the technical problem, the invention provides a marine polypeptide for preparing an osteoporosis medicine, the marine polypeptide provided by the invention is a wrinkle clam polypeptide, and experiments show that the polypeptide can effectively promote osteogenic differentiation of bone marrow mesenchymal stem cells and can promote proliferation of the bone marrow mesenchymal stem cells, so that the polypeptide can be subsequently used for preparing the medicine for treating osteoporosis.
Description
Technical Field
The invention belongs to the technical field of marine biology, and particularly relates to application of marine biological polypeptide in preparation of a medicine for treating osteoporosis.
Background
Osteoporosis is a disease characterized by a sustained loss of bone mass, accelerated bone metabolism and susceptibility to fracture. Currently, the main treatment mode of osteoporosis still is drug therapy, which is not only expensive, but also requires long-term treatment for patients. Meanwhile, in the treatment process, the medicine generates toxic and side effects, so that the treatment effect is not ideal, and therefore, a new treatment mode needs to be found at present.
Dysfunction of mesenchymal stem cells is one of the pathogenesis of osteoporosis. The mesenchymal stem cell is a cell having a multipotentiality, which can differentiate toward bone, cartilage or fat, and thus, it is a seed cell commonly used in bone tissue engineering. When the osteogenic differentiation and the adipogenic differentiation of the bone marrow mesenchymal stem cells are unbalanced and the osteogenic differentiation of the bone marrow mesenchymal stem cells is less, the fat content in the bone marrow is increased, the bone absorption is increased, and the osteoporosis is caused. Therefore, the effective promotion of the osteogenic transformation of the mesenchymal stem cells is helpful for realizing the treatment of osteoporosis.
The Venerupis philippinarum is an animal of Venerupis philippinarum in Venerupis of Venerupis, and at present, the function of the polypeptide of Venerupis philippinarum in osteogenic differentiation of mesenchymal stem cells of bone marrow is not reported.
Disclosure of Invention
The invention aims to provide a marine biological polypeptide capable of effectively promoting osteogenic differentiation of bone marrow mesenchymal stem cells, so that the marine biological polypeptide can be further used for preparing a medicine for treating osteoporosis.
In order to achieve the above purpose, the present invention provides the following technical solutions:
the invention provides an application of a wrinkle clam polypeptide in preparation of an osteoporosis medicine.
Preferably, the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
Secondly, the invention provides an application of the wrinkle clam polypeptide in preparing a bone marrow mesenchymal stem cell osteogenic differentiation enhancing medicine.
Preferably, the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
Thirdly, the invention provides an application of the wrinkle clam polypeptide in preparing a medicament for enhancing the expression of a bone marrow mesenchymal stem cell osteogenic differentiation promoting factor RUNX2 protein.
Preferably, the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
The invention also provides application of the clam polypeptide in preparing a medicament for enhancing the ALP enzyme activity of the mesenchymal stem cells.
The invention also provides application of the clam polypeptide in preparation of a medicine for enhancing cell calcification of mesenchymal stem cells.
The invention further provides an application of the wrinkle clam polypeptide in preparation of a proliferation enhancing medicine of the bone marrow mesenchymal stem cells.
Preferably, the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
The invention has the beneficial effects that:
the wrinkle clam polypeptide is prepared by the invention, and experiments show that the wrinkle clam polypeptide prepared by the invention can effectively promote the protein expression of osteogenic differentiation promoting factor RUNX2 of the bone marrow mesenchymal stem cells, can effectively promote the ALP enzyme activity and the cell calcification level of the bone marrow mesenchymal stem cells, and can effectively promote the proliferation of the bone marrow mesenchymal stem cells. Therefore, the wrinkle clam polypeptide prepared by the invention can be used for preparing medicines for promoting osteogenic differentiation of bone marrow mesenchymal stem cells and further treating osteoporosis.
Drawings
FIG. 1 shows the effect of cockle polypeptides on the expression of protein of bone marrow mesenchymal stem cell osteogenic differentiation promoting factor RUNX 2;
FIG. 2 shows the results of an alkaline phosphatase staining experiment;
FIG. 3 shows the results of alizarin red staining experiments;
FIG. 4 shows the effect of cockle polypeptides on the proliferation of mesenchymal stem cells.
Detailed Description
In order to clearly illustrate the technical features of the present solution, the present solution is explained below by way of specific embodiments.
Example 1
(1) Cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing 100g of the wrinkled clam powder into a container, adding 500g of distilled water, uniformly mixing, adjusting the pH to 8, adding 3g of trypsin, and carrying out water bath enzymolysis at 37 ℃ for 6 hours;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
Example 2
Regulation effect of ruga clam polypeptide on RUNX2 protein in osteogenic differentiation process
(1) 1.5X 10 of good growth state4The P3 generation human bone marrow mesenchymal stem cells are inoculated in a 6-well plate;
(2) when the cell density reached 80%, the control group: complete medium culture was used, experimental group 1: culturing in osteogenic differentiation medium, wherein in the experimental group 2, the osteogenic differentiation medium added with 250ug/ml wrinkle clam polypeptide is cultured; experimental group 3: culturing in osteogenic differentiation medium supplemented with 500ug/ml wrinkle clam polypeptide;
(3) after culturing for 7 days, removing the culture medium, adding cell lysate, scraping the cells by using a cell scraper, and then collecting the lysate into an EP tube;
(4) after cracking for 30min, placing the mixture in a centrifuge for centrifugation, collecting supernatant, and preparing a protein sample after measuring the protein concentration;
(5) preparing concentrated gel and split gel, loading a protein sample, performing constant pressure of 80V until bromophenol blue reaches the split gel, and adjusting to 120V until electrophoresis is finished;
(5) soaking the PVDF membrane in methanol for 15s, activating, then carrying out electric rotating clamp installation, and adjusting a power supply to be a constant current of 250mA for 1.5 h;
(6) after the electrotransformation is finished, taking out the PVDF membrane, putting the PVDF membrane in 5% skimmed milk powder, and sealing for 1 h;
(7) incubating RUNX2 and GAPDH primary antibody after closing, incubating overnight at 4 ℃, and washing the PVDF membrane for 3 times (10 min each time) by TBST after the incubation is finished;
(8) then, incubating corresponding secondary antibodies, incubating at room temperature for 1h, and washing the PVDF membrane for 3 times by using TBST, wherein each time is 10 min;
(9) the PVDF membrane is developed under the condition of keeping out of the light.
The results obtained by the experiment are shown in fig. 1, and it can be seen that after the wrinkle clam polypeptide is added, the protein expression level of an osteogenic differentiation promoting factor RUNX2 is obviously improved in the osteogenic differentiation process of human bone marrow mesenchymal stem cells, which indicates that the wrinkle clam polypeptide provided by the invention can effectively promote the protein expression of RUNX 2.
Example 2
Regulation of ALP enzyme activity in osteogenic differentiation process by cripple clam polypeptide
(1) 1.5X 10 of good growth state4The P3 generation mesenchymal stem cells are inoculated in a 6-well plate;
(2) when the cell density reaches 80%, adding osteogenic differentiation culture medium into the control group for culture, adding osteogenic differentiation culture medium into the experimental group for culture, adding 500ug/ml wrinkle clam polypeptide into the experimental group for culture, changing the culture solution once every 2-3 days, and setting 3 repeats in each group;
(3) after culturing for 7 days, removing the culture medium, gently cleaning cells by using PBS, and adding 4% paraformaldehyde to fix the cells for 30 min;
(4) removing paraformaldehyde, washing cells with PBS, and treating cells according to the alkaline phosphatase kit instructions;
(5) after the processing is finished, photographing is carried out.
The results obtained by the experiment are shown in fig. 2, and it can be seen that the ALP staining degree in the experimental group is significantly higher than that in the control group, and the results show that the wrinkle clam polypeptide prepared by the invention can effectively promote the activity of ALP enzyme in mesenchymal stem cells.
Example 3
Regulation of cell calcification in osteogenic differentiation process by wrinkle clam polypeptide
(1) 1.5X 10 of good growth state4The P3 generation mesenchymal stem cells are inoculated in a 6-well plate;
(2) when the cell density reaches 80%, adding osteogenic differentiation culture medium into the control group for culture, adding osteogenic differentiation culture medium into the experimental group for culture, adding 500ug/ml wrinkle clam polypeptide into the experimental group for culture, changing the culture solution once every 2-3 days, and setting 3 repeats in each group;
(3) after culturing for 7 days, removing the culture medium, gently cleaning cells by using PBS, and adding 4% paraformaldehyde to fix the cells for 30 min;
(4) removing paraformaldehyde, washing cells with PBS, and incubating for 30min at room temperature in a dark place with alizarin red staining solution;
(6) alizarin red staining solution was removed, and cells were washed 2 times with PBS and photographed.
The results obtained by the experiment are shown in fig. 3, and it can be seen that the description of the cell mineralized nodules in the experimental group is obviously more than that in the control group, and the results show that the wrinkle clam polypeptide prepared by the invention can effectively promote the calcification of the mesenchymal stem cells in the bone marrow.
Example 4
(1) 1X 10 prepared from P3 generation mesenchymal stem cells with good growth state4Each hole is connected with 100ul of single cell suspension of ml, and 3 multiple holes are arranged;
(2) after inoculation, putting the culture medium into a cell culture box, changing the culture medium after 24h, adding a complete culture medium into a control group for culture, and adding a complete culture medium of 500ug/ml wrinkle clam polypeptide into an experimental group;
(3) taking out after culturing for 1,3 and 5 days respectively, adding 10ul of CCK-8 into each hole, and placing in a cell culture box for further incubation for 4 hours;
(4) after the incubation is finished, the OD average value of each group is measured by using an enzyme-linked immunosorbent assay instrument, and the detection wavelength is 450 nm.
The results obtained by the experiment are shown in fig. 4, and it can be seen from the figure that the OD values of the experimental group are significantly higher than those of the control group when the cells are cultured for 3d and 5d, and the difference has statistical significance, and the results show that the proliferation capacity of the mesenchymal stem cells can be effectively promoted by adding the wrinkle clam polypeptide.
Claims (10)
1. An application of wrinkle clam polypeptide in preparing osteoporosis medicine is provided.
2. The use according to claim 1, wherein the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
3. An application of wrinkle clam polypeptide in preparing the medicines for increasing the osteogenic differentiation of bone marrow mesenchymal stem cells is disclosed.
4. The use according to claim 3, wherein the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
5. An application of a wrinkle clam polypeptide in preparing a medicament for enhancing expression of a bone marrow mesenchymal stem cell osteogenic differentiation promoting factor RUNX2 protein.
6. The use according to claim 5, wherein the preparation method of the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
7. An application of short necked clam polypeptide in preparing medicine for enhancing ALP enzyme activity of mesenchymal stem cells of bone marrow.
8. An application of the polypeptide of cockle in preparing the medicine for increasing the calcification of bone marrow mesenchymal stem cells is disclosed.
9. An application of wrinkle clam polypeptide in preparing the medicine for increasing the proliferation of bone marrow mesenchymal stem cells is disclosed.
10. The use according to any one of claims 7 to 9, wherein the method for preparing the wrinkle clam polypeptide comprises the following steps:
(1) cleaning the clam, drying the clam meat, and putting the dried clam meat into a grinder for grinding to obtain clam meat powder;
(2) placing the wrinkled clam powder into a container, adding distilled water of which the mass is 5 times that of the powder, uniformly mixing, adjusting the pH to 8, adding trypsin of which the mass is 0.5% that of the solution, and carrying out water bath enzymolysis for 6 hours at 37 ℃;
(3) after enzymolysis, heating to 100 ℃, and heating for 20min to inactivate enzyme;
(4) centrifuging to collect supernatant, filtering with 3000Da ultrafiltration membrane, collecting permeate, and freeze drying to obtain Concha Meretricis Seu Cyclinae polypeptide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111408458.7A CN113817792B (en) | 2021-11-25 | 2021-11-25 | Application of marine biological polypeptide in preparation of medicine for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111408458.7A CN113817792B (en) | 2021-11-25 | 2021-11-25 | Application of marine biological polypeptide in preparation of medicine for treating osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113817792A true CN113817792A (en) | 2021-12-21 |
| CN113817792B CN113817792B (en) | 2022-04-01 |
Family
ID=78918257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111408458.7A Active CN113817792B (en) | 2021-11-25 | 2021-11-25 | Application of marine biological polypeptide in preparation of medicine for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113817792B (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102125686A (en) * | 2011-01-31 | 2011-07-20 | 中国科学院海洋研究所 | Application of hard clam polypeptide |
| CN102161699A (en) * | 2011-01-31 | 2011-08-24 | 中国科学院海洋研究所 | Clam polypeptide and preparation method thereof |
| CN102372765A (en) * | 2010-08-05 | 2012-03-14 | 浙江海洋学院 | Ruditapes philippinarum enzymatic polypeptide and preparation method thereof |
| CN104436168A (en) * | 2013-09-12 | 2015-03-25 | 林佳静 | Composition for promoting cell regeneration and preparation method and purpose thereof |
| CN107616507A (en) * | 2017-09-26 | 2018-01-23 | 大连大学 | A kind of ocean polypeptide spy's dietary seafood for chornic arthritis edible for patients |
| CN111690598A (en) * | 2020-07-14 | 2020-09-22 | 山东殷氏干细胞有限公司 | Solen oligopeptide, and preparation method and application thereof |
| CN112617211A (en) * | 2020-12-17 | 2021-04-09 | 福建省水产研究所（福建水产病害防治中心） | Preparation method of eel bone polypeptide for treating osteoporosis |
| CN112877287A (en) * | 2020-06-22 | 2021-06-01 | 青岛思拓新源细胞医学有限公司 | Application of bullacta exarata polypeptide in preparation of osteogenic differentiation accelerant for mesenchymal stem cells |
| WO2021142880A1 (en) * | 2020-01-16 | 2021-07-22 | 美国琛蓝营养制品股份有限公司 | Method for producing clam active peptide |
-
2021
- 2021-11-25 CN CN202111408458.7A patent/CN113817792B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102372765A (en) * | 2010-08-05 | 2012-03-14 | 浙江海洋学院 | Ruditapes philippinarum enzymatic polypeptide and preparation method thereof |
| CN102125686A (en) * | 2011-01-31 | 2011-07-20 | 中国科学院海洋研究所 | Application of hard clam polypeptide |
| CN102161699A (en) * | 2011-01-31 | 2011-08-24 | 中国科学院海洋研究所 | Clam polypeptide and preparation method thereof |
| CN104436168A (en) * | 2013-09-12 | 2015-03-25 | 林佳静 | Composition for promoting cell regeneration and preparation method and purpose thereof |
| CN107616507A (en) * | 2017-09-26 | 2018-01-23 | 大连大学 | A kind of ocean polypeptide spy's dietary seafood for chornic arthritis edible for patients |
| WO2021142880A1 (en) * | 2020-01-16 | 2021-07-22 | 美国琛蓝营养制品股份有限公司 | Method for producing clam active peptide |
| CN112877287A (en) * | 2020-06-22 | 2021-06-01 | 青岛思拓新源细胞医学有限公司 | Application of bullacta exarata polypeptide in preparation of osteogenic differentiation accelerant for mesenchymal stem cells |
| CN111690598A (en) * | 2020-07-14 | 2020-09-22 | 山东殷氏干细胞有限公司 | Solen oligopeptide, and preparation method and application thereof |
| CN112617211A (en) * | 2020-12-17 | 2021-04-09 | 福建省水产研究所（福建水产病害防治中心） | Preparation method of eel bone polypeptide for treating osteoporosis |
Non-Patent Citations (3)
| Title |
|---|
| YOUNG RAN PARK ET AL.: ""Antioxidant and Anti-Inflammatory Effects of NCW Peptide from Clam Worm (Marphysa sanguinea)"", 《J. MICROBIOL. BIOTECHNOL.》 * |
| 冷波等: ""胰蛋白酶酶解文蛤制备文蛤多肽的研究"", 《漳州师范学院学报》 * |
| 牛红鑫等: ""青蛤活性物质的研究现状"", 《农产品加工》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113817792B (en) | 2022-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114404441B (en) | Promoter for bone marrow mesenchymal stem cell osteogenic differentiation | |
| CN109136174B (en) | Stem cell-derived exosome preparation for delaying senescence | |
| CN112206356A (en) | Injectable bone repair hydrogel containing human umbilical cord mesenchymal stem cell exosomes and preparation method thereof | |
| CN103223194A (en) | Cartilage graft for cartilage injury repair and preparation method thereof | |
| CN114606186B (en) | Method for improving proliferation of umbilical cord mesenchymal stem cells | |
| CN113088487A (en) | Mesenchymal stem cell adipogenic transformation inhibitor | |
| CN113817792B (en) | Application of marine biological polypeptide in preparation of medicine for treating osteoporosis | |
| CN112877287B (en) | Application of bullacta exarata polypeptide in preparation of osteogenic differentiation accelerant for mesenchymal stem cells | |
| CN116904398A (en) | Culture medium for rapid expansion and activity enhancement of CAR-T cells | |
| CN116716243A (en) | Application of clematis root glycoside in promoting growth and osteogenic differentiation of dental pulp stem cells | |
| CN115478050B (en) | Method for improving stem cell in vitro amplification capacity | |
| CN108543112B (en) | Preparation method of sericin-agarose composite gel with cell proliferation promoting activity and product thereof | |
| CN114939123A (en) | Therapeutic preparation for promoting wound repair | |
| CN104789590A (en) | Method for obtaining bioactive substance composition through immortalized cells | |
| CN114934089B (en) | Biological agent for lean pork pig breeding | |
| CN114107184B (en) | Application of siRNA in osteogenic differentiation of dental pulp stem cells | |
| CN115010821B (en) | Application of polysaccharide in promoting growth of umbilical cord mesenchymal stem cells | |
| CN118240883B (en) | Umbilical cord mesenchymal stem cells with enhanced inflammatory regulation capability, application and preparation method thereof | |
| CN115350196B (en) | Biological preparation for reducing skin aging and improving skin injury repair | |
| CN113151279B (en) | hsa_circ_0001236 and application thereof | |
| CN114921404B (en) | Method for promoting mineralization of dental pulp stem cells | |
| CN113717935B (en) | Application of Nigroain-E1 polypeptide in maintaining adipose-derived stem cell (Stem) stem property | |
| CN117778312A (en) | Complete culture medium for improving stem cell dryness maintenance capacity | |
| CN116236624A (en) | Decalcified human tooth matrix material and decalcified human tooth matrix manufacturing method | |
| CN101613709B (en) | Method for improving transfection efficiency of gene transfected pigskin by diethylaminoethyl glucan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |